• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Health Care Supplies

InVivo Therapeutics Holdings Corp

+ Add to Watchlist

NVIV:US

1.6000 USD 0.0200 1.27%

As of 20:10:00 ET on 04/17/2014.

Snapshot for InVivo Therapeutics Holdings Corp (NVIV)

Open: 1.5900 Day's Range: 1.5200 - 1.6800 Volume: 55,847
Previous Close: 1.5800 52wk Range: 0.9400 - 6.2000 1-Yr Rtn: -49.53%

Stock Chart for NVIV

No chart data available.
  • NVIV:US 1.6000
  • 1D
  • 1M
  • 1Y
1.5800
Interactive NVIV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVIV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2600
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 126.39
Shares Outstanding (M) 78.99
30 Day Average Volume 172,320
Price/Book (mrq) 7.1593
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVIV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVIV

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Mark D PerrinChief Executive OfficerSteven McAllister "Steve"Interim CFO
Brian HessChief Technology OfficerThomas R UlichChief Scientific Officer
More Company Profile & Key Executives for NVIV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil